Cargando…

EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial

BACKGROUND AND OBJECTIVE: Endosonography with intrathoracic nodal sampling is proposed as the single test with the highest granuloma detection rate in suspected sarcoidosis stage I/II. However, most studies have been performed in limited geographical regions. Studies suggest that oesophageal endoson...

Descripción completa

Detalles Bibliográficos
Autores principales: Crombag, Laurence M. M., Mooij‐Kalverda, Kirsten, Szlubowski, Artur, Gnass, Maciej, Tournoy, Kurt G., Sun, Jiayuan, Oki, Masahide, Ninaber, Maarten K., Steinfort, Daniel P., Jennings, Barton R., Liberman, Moishe, Bilaceroglu, Semra, Bonta, Peter I., Korevaar, Daniël A., Trisolini, Rocco, Annema, Jouke T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299594/
https://www.ncbi.nlm.nih.gov/pubmed/34792268
http://dx.doi.org/10.1111/resp.14182
_version_ 1784751009472446464
author Crombag, Laurence M. M.
Mooij‐Kalverda, Kirsten
Szlubowski, Artur
Gnass, Maciej
Tournoy, Kurt G.
Sun, Jiayuan
Oki, Masahide
Ninaber, Maarten K.
Steinfort, Daniel P.
Jennings, Barton R.
Liberman, Moishe
Bilaceroglu, Semra
Bonta, Peter I.
Korevaar, Daniël A.
Trisolini, Rocco
Annema, Jouke T.
author_facet Crombag, Laurence M. M.
Mooij‐Kalverda, Kirsten
Szlubowski, Artur
Gnass, Maciej
Tournoy, Kurt G.
Sun, Jiayuan
Oki, Masahide
Ninaber, Maarten K.
Steinfort, Daniel P.
Jennings, Barton R.
Liberman, Moishe
Bilaceroglu, Semra
Bonta, Peter I.
Korevaar, Daniël A.
Trisolini, Rocco
Annema, Jouke T.
author_sort Crombag, Laurence M. M.
collection PubMed
description BACKGROUND AND OBJECTIVE: Endosonography with intrathoracic nodal sampling is proposed as the single test with the highest granuloma detection rate in suspected sarcoidosis stage I/II. However, most studies have been performed in limited geographical regions. Studies suggest that oesophageal endosonographic nodal sampling has higher diagnostic yield than endobronchial endosonographic nodal sampling, but a head‐to‐head comparison of both routes has never been performed. METHODS: Global (14 hospitals, nine countries, four continents) randomized clinical trial was conducted in consecutive patients with suspected sarcoidosis stage I/II presenting between May 2015 and August 2017. Using an endobronchial ultrasound (EBUS) scope, patients were randomized to EBUS or endoscopic ultrasound (EUS)‐B‐guided nodal sampling, and to 22‐ or 25‐G ProCore needle aspiration (2 × 2 factorial design). Granuloma detection rate was the primary study endpoint. Final diagnosis was based on cytology/pathology outcomes and clinical/radiological follow‐up at 6 months. RESULTS: A total of 358 patients were randomized: 185 patients to EBUS‐transbronchial needle aspiration (EBUS‐TBNA) and 173 to EUS‐B‐fine‐needle aspiration (FNA). Final diagnosis was sarcoidosis in 306 patients (86%). Granuloma detection rate was 70% (130/185; 95% CI, 63–76) for EBUS‐TBNA and 68% (118/173; 95% CI, 61–75) for EUS‐B‐FNA (p = 0.67). Sensitivity for diagnosing sarcoidosis was 78% (129/165; 95% CI, 71–84) for EBUS‐TBNA and 82% (115/141; 95% CI, 74–87) for EUS‐B‐FNA (p = 0.46). There was no significant difference between the two needle types in granuloma detection rate or sensitivity. CONCLUSION: Granuloma detection rate of mediastinal/hilar nodes by endosonography in patients with suspected sarcoidosis stage I/II is high and similar for EBUS and EUS‐B. These findings imply that both diagnostic tests can be safely and universally used in suspected sarcoidosis patients.
format Online
Article
Text
id pubmed-9299594
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-92995942022-07-21 EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial Crombag, Laurence M. M. Mooij‐Kalverda, Kirsten Szlubowski, Artur Gnass, Maciej Tournoy, Kurt G. Sun, Jiayuan Oki, Masahide Ninaber, Maarten K. Steinfort, Daniel P. Jennings, Barton R. Liberman, Moishe Bilaceroglu, Semra Bonta, Peter I. Korevaar, Daniël A. Trisolini, Rocco Annema, Jouke T. Respirology ORIGINAL ARTICLES BACKGROUND AND OBJECTIVE: Endosonography with intrathoracic nodal sampling is proposed as the single test with the highest granuloma detection rate in suspected sarcoidosis stage I/II. However, most studies have been performed in limited geographical regions. Studies suggest that oesophageal endosonographic nodal sampling has higher diagnostic yield than endobronchial endosonographic nodal sampling, but a head‐to‐head comparison of both routes has never been performed. METHODS: Global (14 hospitals, nine countries, four continents) randomized clinical trial was conducted in consecutive patients with suspected sarcoidosis stage I/II presenting between May 2015 and August 2017. Using an endobronchial ultrasound (EBUS) scope, patients were randomized to EBUS or endoscopic ultrasound (EUS)‐B‐guided nodal sampling, and to 22‐ or 25‐G ProCore needle aspiration (2 × 2 factorial design). Granuloma detection rate was the primary study endpoint. Final diagnosis was based on cytology/pathology outcomes and clinical/radiological follow‐up at 6 months. RESULTS: A total of 358 patients were randomized: 185 patients to EBUS‐transbronchial needle aspiration (EBUS‐TBNA) and 173 to EUS‐B‐fine‐needle aspiration (FNA). Final diagnosis was sarcoidosis in 306 patients (86%). Granuloma detection rate was 70% (130/185; 95% CI, 63–76) for EBUS‐TBNA and 68% (118/173; 95% CI, 61–75) for EUS‐B‐FNA (p = 0.67). Sensitivity for diagnosing sarcoidosis was 78% (129/165; 95% CI, 71–84) for EBUS‐TBNA and 82% (115/141; 95% CI, 74–87) for EUS‐B‐FNA (p = 0.46). There was no significant difference between the two needle types in granuloma detection rate or sensitivity. CONCLUSION: Granuloma detection rate of mediastinal/hilar nodes by endosonography in patients with suspected sarcoidosis stage I/II is high and similar for EBUS and EUS‐B. These findings imply that both diagnostic tests can be safely and universally used in suspected sarcoidosis patients. John Wiley & Sons, Ltd 2021-11-17 2022-02 /pmc/articles/PMC9299594/ /pubmed/34792268 http://dx.doi.org/10.1111/resp.14182 Text en © 2021 The Authors. Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle ORIGINAL ARTICLES
Crombag, Laurence M. M.
Mooij‐Kalverda, Kirsten
Szlubowski, Artur
Gnass, Maciej
Tournoy, Kurt G.
Sun, Jiayuan
Oki, Masahide
Ninaber, Maarten K.
Steinfort, Daniel P.
Jennings, Barton R.
Liberman, Moishe
Bilaceroglu, Semra
Bonta, Peter I.
Korevaar, Daniël A.
Trisolini, Rocco
Annema, Jouke T.
EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial
title EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial
title_full EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial
title_fullStr EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial
title_full_unstemmed EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial
title_short EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial
title_sort ebus versus eus‐b for diagnosing sarcoidosis: the international sarcoidosis assessment (isa) randomized clinical trial
topic ORIGINAL ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299594/
https://www.ncbi.nlm.nih.gov/pubmed/34792268
http://dx.doi.org/10.1111/resp.14182
work_keys_str_mv AT crombaglaurencemm ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial
AT mooijkalverdakirsten ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial
AT szlubowskiartur ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial
AT gnassmaciej ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial
AT tournoykurtg ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial
AT sunjiayuan ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial
AT okimasahide ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial
AT ninabermaartenk ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial
AT steinfortdanielp ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial
AT jenningsbartonr ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial
AT libermanmoishe ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial
AT bilaceroglusemra ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial
AT bontapeteri ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial
AT korevaardaniela ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial
AT trisolinirocco ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial
AT annemajouket ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial